Appropriate balance between excitatory and inhibitory neural activity patterns is of utmost importance in the maintenance of neuronal homeostasis. General anesthetic-induced pharmacological interference with this equilibrium results not only in a temporary loss of consciousness but can also initiate long-term changes in brain function. Although these alterations were initially considered deleterious, recent observations suggest that at least under some specific conditions, they may eventually improve neural function. The goal of this review is to provide insights into the mechanisms underlying these dual effects. Basic science issues on the important role of critical periods during neural circuitry assembly will be discussed to better understand how even brief exposures to general anesthetics could initiate context-dependent lasting changes in neuronal structure and function. Recent series of observations suggesting a developmental stage-dependent impact of these drugs on synaptogenesis will then be summarized together with currently known molecular mechanisms underlying these effects. Particular emphasis will be placed on how anesthetic drugs modulate neural plasticity in the adult brain and how this may improve neural function under some pathological states. The ensemble of these new observations strongly suggests that general anesthetics should not merely be considered toxic drugs but rather acknowledged as robust, context-dependent modulators of neural plasticity.
F inely tuned information processing is the most fundamental feature of the central nervous system (CNS). A major determinant of this ever-changing and tremendously orchestrated function is the highly dynamic communication between neurons via specialized structures, called synapses. Intense synaptic development during the brain growth spurt period underlies the formation of functional neural networks, and importantly, increasing evidence also indicates a role for synapse formation/elimination in the context of adult neural plasticity. 1, 2 Neural activity plays a substantial role in these processes and overwhelming evidence indicates that synaptogenesis and circuitry assembly are highly dependent on the functional balance between excitatory and inhibitory signaling mechanisms. 3 Interference with physiological patterns of excitation/inhibition (E/I) activity during development has been shown to have tremendous impact on the fine tuning of neuronal networks, and may thus provide a pathological basis for a variety of neurodevelopmental disorders ranging from autism to schizophrenia. [4] [5] [6] General anesthetics (GA) are powerful modulators of γ-aminobutyric acid (GABA)-ergic and glutamatergic neurotransmission. 7 In this context, an intriguing possibility is that exposure to these drugs might exert a major influence on E/I balance and thus on synaptogenesis and network formation. In line with this hypothesis, recent experimental observations suggest that anesthetics indeed modify synaptogenesis during the brain growth spurt. Importantly, these drugs might also influence synaptic plasticity at later developmental stages, and this may have clinical relevance under defined pathological states in adult humans. The ensemble of these new data points to an emerging novel role for GA as modulators of synaptic plasticity, a concept that is fundamentally different from the issue of GA-induced neurotoxicity. The goal of this review is to highlight this possibility and to provide insights into our current understanding on how anesthetics might modulate synaptogenesis and neural plasticity during development and in adulthood.
FROM RODENTS TO HUMANS: COMPARATIVE ONTOGENY OF SYNAPSE FORMATION
Synapse formation in the vertebrate CNS occurs over a protracted period of development, extending from early embryonic life into adulthood. The most intense phase of synaptogenesis, often referred as the brain growth spurt, is highly species dependent. In the rodent cerebral cortex, this period is limited to a relatively narrow time window, taking place between the second and fourth postnatal weeks. 8, 9 The brain region-specific temporal evolution pattern of synaptogenesis is by far the most described in the rhesus monkey, in which an up to 17-fold increase in the number of synapses occurs within a few months during the perinatal period. 10 In humans, on the basis of analysis of postmortem tissue, a comparable extension in the number of synapses is observed between the third trimester of pregnancy and the first few years of postnatal life. [11] [12] [13] [14] In all these aforementioned species, the perinatal exponential synaptic growth leads to an initial overproduction of synapses and then to a selective pruning of synaptic contacts extending from puberty to adolescents and beyond. [8] [9] [10] 14 The fact that developmental synaptogenesis is speciesspecifically actively continuing over a period of weeks to years has important implications regarding experimental design and extrapolation of animal data to human relevance. In fact, since significant evolution in ionotropic receptor systems and transporters is observed during the brain growth spurt, functional characteristics of ionotropic receptor-mediated neurotransmissions can be fundamentally different between earlier and later stages of this period. For example, complex region-and developmental stagespecific subunit expression patterns have been described for both GABA A and glutamate receptors. [15] [16] [17] [18] Of utmost importance, because of high intracellular concentrations of chloride in comparison with the extracellular space, GABA A receptor-mediated neurotransmission is depolarizing during the early phase of the brain growth spurt. 19, 20 The functional switch towards the hyperpolarizing actions of this neurotransmitter is linked to the developmental expression of the K + -Cl − cotransporter KCC2, which extrudes actively intracellular Cl − from neurons. 21 A significant increase in the expression pattern of this protein occurs between the 10th and 14th postnatal days in rodents 22, 23 and from approximately the 32nd postconception week in humans. 24 The ensemble of these observations thus strongly suggests a differential impact of GA on neurotransmitter systems and related neural network formation at distinct stages of the brain growth spurt. Hence, in laboratory investigations aimed to evaluate potential anesthesia-related adverse neurodevelopmental effects, focusing on one sole experimental timepoint most probably does not allow us to draw general conclusions on the effect of a given drug on synaptic growth.
CRITICAL PERIOD PLASTICITY DURING THE BRAIN GROWTH SPURT: A ROLE FOR NEURAL ACTIVITY
The decisive role of early experience to prime life-long behavioral patterns has been well recognized since the pioneering work of Spalding, who using domestic chickens revealed how these young animals acquire behavioral patterns from their parents during the early postnatal period. 25 A century later, this concept of filial imprinting was further developed in a seminal series of experiments by Lorenz, demonstrating how incubator-hatched greylag geese would imprint on the first suitable stimulus they saw within a well-defined temporal window between 13 to 16 hours shortly after hatching. 26 These early observations provided strong evidence on the long-term impact of brief stimuli when applied at critical developmental stages. Today, critical periods are defined as brain region-specific and temporally restricted time windows when brain circuits that subserve a given function are particularly receptive to acquiring certain kinds of information, or even need that instructive signal for their continued normal development. 3 A well-known, clinically relevant example to demonstrate the importance of critical periods is functional amblyopia, defined as poor vision due to abnormal visual experience early in life. In this clinical entity, conditions leading to any form of visual deprivation (e.g., strabismus, anisometropia, myopia) will interfere with the physiological refinement of visual pathways occurring during the first few years of life and can thus lead to lifelong visual impairment. 27 Importantly, the earlier the intervention is performed to correct the deficit, the better long-term outcome is observed. 28 Language acquisition is another example of how increased neural plasticity is restricted to critical periods: the innate ability to acquire language declines gradually after 6 years of life and slows significantly after the age of 12 years. 29 Perhaps the most striking demonstration of intensely continuing neural plasticity in the young brain is the observation of normal language acquisition in children younger than 4 years of age after removal of the entire left cerebral hemisphere, an intervention that would lead to permanent loss of language functions in adults. 30 Despite the important differences regarding the amplitude of plasticity between early postnatal life and later stages of development, it is important to realize that plasticity still occurs in the adult brain, although to a much lesser extent. Understanding the molecular, cellular, and systemic mechanisms underlying these differences could ultimately allow us to remove brakes on adult brain plasticity that, in turn, would have fundamental implications regarding cognition, learning, or recovery after brain injury. 3, 31 It is now well established that while type-specific morphology of CNS neurons appear to rely on genetically defined intrinsic developmental programs, 32 experience-driven electrical activity patterns exert a preponderant influence on neural network development in the early postnatal period. 33 At the cellular level, activity-induced changes in intracellular Ca 2+ concentrations are central to these processes. 34 In presynaptic neurons, a depolarization-induced increase in intracellular Ca 2+ contents results in presynaptic release of neurotransmitters. In turn, neurotransmitters will then activate their receptors on postsynaptic neurons and concomitantly alter Ca 2+ levels in these cells. Activation of Ca 2+ -dependent cytoplasmic effectors can then initiate a wide variety of events aimed to modify both short-and long-term neuronal excitability and synaptic efficacy, including trophic factor secretion, changes in the expression patterns of cell surface receptors, and the initiation of changes in gene expression and protein synthesis. 35, 36 Importantly, electrical activity also exerts direct effects on the transduction efficacy of both intracellular and membrane proteins. 37, 38 Indeed, synaptic current-generated focal electric fields can guide electrophoretic or electro-osmotic migration of various intracellular components, such as receptors and transporters, into the cell membrane or within the cytoplasm. 39, 40 This, in turn, would lead to gradients in the cellular distribution patterns of these molecules, thereby facilitating specific molecular interactions and localizations at synaptic sites. The ensemble of these aforementioned processes might be essential in axonal pathfinding and target selection as well www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA as in the maturation of synaptic structures. At the network level, temporal patterns of electrical activities play a substantial role in shaping synaptic connectivity. 41, 42 In fact, after the initial formation of numerous synaptic contacts, refinement of neural circuitry implies elimination of some and strengthening of other synapses. 42, 43 Rewiring of neural connectivity depends upon electrical activity patterns dictated by cooperative and competitive inputs onto postsynaptic cells. Interference with physiological activity patterns can exert major impact on circuitry refinement. One striking demonstration of this possibility is that synchronous artificial activation of optic nerves blocks the development of topographic maps in the optic tectum 44 and reduces orientation selectivity in the visual cortex. 45 In all species, the highly intense phase of synaptogenesis through early postnatal life coincides with critical periods of plasticity in most cortical regions. 3, 10 During these periods, a delicate physiological balance between excitatory and inhibitory inputs is required to properly guide neural circuitry assembly. In the developing brain, this equilibrium is primarily controlled through balancing excitatory and inhibitory synaptogenesis, and mutations of genes involved in sculpting and maintaining this balance result in severe dysfunctions underlying neurodevelopmental disorders such as autism, epilepsy, or Rett syndrome. 46 In addition to these genetic instructions, pharmacological interference with physiological patterns of E/I balance during critical periods of development can have significant long-term effects on neural circuitry assembly and function. Through drug-induced targeting of GABAergic and glutamatergic neurotransmission, both hyperexcitation and silencing of neural networks have been shown to disrupt critical period plasticity, leading thereby to markedly altered information processing in the CNS. 47, 48 Of utmost importance, a more recent series of experiments shed light on the particular role of GABA A receptor-mediated neurotransmission on the control of timing regarding the onset and the duration of critical period plasticity. 49, 50 Indeed, the onset of critical periods can be brought forward by enhancing GABAergic neurotransmission with benzodiazepines or by promoting the maturation of interneurons through excess of brain-derived neurotrophic factor (BDNF) expression. Conversely, delaying maturation of GABAergic systems delays the onset of plasticity. These findings are of fundamental importance and constitute the first steps toward understanding how critical period plasticity can be manipulated to enable the development of novel training paradigms and therapies for effective life-long learning or recovery after brain injuries.
IMPACT OF GENERAL ANESTHETICS ON SYNAPTOGENESIS DURING THE BRAIN GROWTH SPURT
GAs are powerful modulators of a wide variety of ligand-gated ionotropic receptor-mediated neurotransmitter systems. 7 Given the aforementioned importance of these neurotransmitters in activity-dependent synaptogenesis during brain development, anesthetic-induced modulation of neural circuitry assembly is a plausible hypothesis. A substantial amount of initial research addressed this issue in the context of environmental exposure of pregnant operating room personnel to anesthesia gases such as halothane. [51] [52] [53] [54] Using experimental paradigms in which rats were chronically exposed to low concentrations of halothane in utero, during the early postnatal period, or both, the ensemble of these studies revealed that administration of this drug during CNS development permanently impaired dendritic arbor development, decreased synapse density, and induced significant functional deficits in learning and behavior.
The impact of anesthetics on synaptogenesis during the brain growth spurt has only recently been addressed. In rodents, a 6-hour exposure to a mixture of midazolamnitrous oxide-isoflurane anesthesia induced neuropil scarcity, mitochondrial degeneration, and a 30%-40% decrease of synaptic profiles in the developing subiculum when evaluated 2 weeks after exposure to this experimental protocol. 55 In-depth morphometric analysis of synaptic structure revealed a comparable loss of both excitatory and inhibitory synapses in the anesthesia-exposed group. Also, the relative ratios between axo-spinous and axo-dendritic synaptic contacts between drug-exposed and control littermates remained comparable, further suggesting a lasting and nonselective synaptotoxicity of anesthetics under these experimental conditions. In a subsequent recent work, the authors also demonstrated a significant decrease of mitochondrial profiles in presynaptic terminals following the same anesthesia regimen, 56 and this was correlated with highly disturbed synaptic transmission in the subiculum 56 as well as in the CA1 region of the hippocampal formation. 57 Because the important roles of mitochondria in fueling synaptogenesis and maintaining synaptic plasticity are well established, [58] [59] [60] [61] [62] these results suggest that GA-induced interference with mitochondrial homeostasis might play a central role in anesthetic-induced impairment of synaptogenesis and thus of neural network function. They also raise the possibility that pharmacological protection of mitochondria during GA protects developing neural circuitry. In line with this hypothesis, recent laboratory work suggests that mitochondria in fact could be a potential therapeutic target to abolish or at least temper GA-induced morphological damage and related cognitive impairment in the developing brain. 63 A seminal series of recent works provided further insights into the molecular mechanisms involved in GA-induced synaptic loss during the early stages of the brain growth spurt. [64] [65] [66] These studies, conducted principally on 5-to 7-day-old primary neuronal cultures isolated from neonatal rodent brains, reveal a central role for GA-induced modulation of tissue plasminogen activator release and a relatedly altered BDNF signaling in anesthesia-induced synaptic loss and neuroapoptosis. Indeed, in this model, both isoflurane and propofol have been shown to reduce presynaptic release of tissue plasminogen activator that is needed to convert plasminogen to plasmin that, in turn, is required to cleave constitutively released pro-BDNF to mature BDNF. While mature BDNF acts on its high-affinity tyrosine kinase B receptor to promote cell survival and synaptic plasticity, pro-BDNF primarily binds to the low-affinity neurotrophin receptor p75 (p75 NTR ). Activation of p75 NTR , via the downstream effector RhoA kinase, induces actin depolarization and related synapse loss and cell death. In view of earlier in vivo observations, showing that GA brain region-specifically affects BDNF signaling through its receptor systems, 67 these results bring important arguments in favor of the possibility that GAs are powerful modulators of highly relevant signaling pathways implicated in the modulation of neural plasticity.
Dendritic spines are primary postsynaptic sites of excitatory synaptic contacts onto pyramidal neurons. These structures are particularly well suited for studying morphofunctional aspects of synaptogenesis in the developing brain as well as in the adult brain. 68, 69 Given that <4% of dendritic spines lack synapses, 70 changes in dendritic spine densities reflect alterations in the amount of excitatory synaptic inputs onto these principal cells. Importantly, correlation between spine morphology and function is now well established. 71 Among them, spine head volume has been shown to be directly proportional to the size of postsynaptic density, the presynaptic number of docked vesicles, and thus the releasable pool of neurotransmitters. 72, 73 Iontophoretic injection of Lucifer Yellow into pyramidal neurons is an extensively validated method to reliably reveal dendritic spine morphology. 74, 75 Using this technique, and in line with ultrastructural data, 9 we have recently shown a mt10-fold increase in dendritic spine densities of layer 5 pyramidal neurons during the first postnatal month in the rat medial prefrontal cortex. 76 To assess how GAs affect this intense dendritic spine growth on these neurons, we exposed rat pups to propofol at distinct developmental time points throughout the brain growth spurt. 76 These experiments revealed that the effect of propofol on dendritic spines depends on the developmental stage at which this drug is administered. In fact, when administered at postnatal day 5 or 10, even a single dose of propofol induced a significant decrease in the number of dendritic spines, while an important increase in spine density was observed when the drug was administered at later stages of the peak synaptogenic period, such as postnatal day 15 or 20. Of utmost importance, the acute effects of propofol exposure on dendritic spines during early postnatal life persisted into adulthood in these animals, suggesting thereby that even brief exposure to this drug could permanently alter circuitry assembly and function. Further research is needed to understand the molecular mechanisms underlying these developmental stage-dependent effects. Since propofol, similarly to the majority of currently used GAs, is a powerful enhancer of GABA A receptor-mediated neurotransmission, one plausible hypothesis is that these differential effects depend on the developmental switch regarding the functional modalities of GABAergic neurotransmission. Indeed, as mentioned above, GABAergic neurotransmission is initially excitatory, and the functional transition toward inhibitory modalities occurs during the second postnatal week in the rodent cerebral cortex. 20, 77 This developmental switch is primarily linked to the expression of the K + -Cl − cotransporter KCC2 that extrudes actively intracellular Cl − from neurons. 20 In the absence of KCC2, exposure to anesthetics thus increases excitation that might ultimately lead to excitotoxicity. In contrast, when KCC2 is present, propofol promotes inhibitory tone in the cerebral cortex. 21 An alternative or concomitant possibility, as recently suggested, 78 is that the developmental stage-dependent effects of anesthetics on circuitry development are related to the important changes in GABA A receptor subunit composition during early postnatal life, [79] [80] [81] which in turn significantly modify GABAergic inhibitory tone modalities. 82 In this context, a role for the α1 subunit of this receptor complex in excitatory synaptogenesis has recently been suggested. In the rodent brain, the expression of the α1 subunit is upregulated around postnatal day 14, and genetic deletion of this subunit results in significantly impaired dendritic spine development. 83 It is also conceivable that, independent of their actions on the GABA A receptor complex, anesthetics can also modify the secretion or signaling pathways of trophic factors that are directly involved in synaptogenesis. Among these molecules, BDNF is an interesting candidate, and as mentioned above, a dual role for this neurotrophin has recently been suggested to explain the developmental stage-dependent effects of anesthetics on synaptogenesis. 64 Finally, it is important to note that the early postnatal period is characterized by major changes in the expression patterns and functions of several molecular classes, including, among others, adhesion molecules, growth factor, and neurotransmitter signaling pathways, all of which are important determinants of synaptogenesis. Clearly, a large number of further studies are needed to investigate these important issues.
The fact that propofol rapidly induces significant increases in dendritic spine densities during the brain growth spurt gives rise to the possibility that GAs could also exert an important impact on the assembly of neural circuitry at developmental stages when these drugs no longer induce neuroapoptosis anymore. To further extend this possibility, in a related series of works, we have shown that other anesthetics-such as volatile agents, midazolam, or ketamine-exert similar boosting effects on dendritic spine densities. 84, 85 The phenomenon of a GA-induced increase in dendritic spine densities is not restricted to the medial prefrontal cortex but could also be found in other cortical regions as well as in the hippocampus. 84 Most important, using quantitative electron microscopy, we have shown that increases in the number of dendritic spines indeed reflect an increase in the number of excitatory synaptic profiles. 76 Altogether, these observations further strengthen the view that GAs can act as powerful modulators of synaptogenesis during critical periods of brain development.
During the early postnatal period, dendritic spines display intense protrusive motility, resulting in the possibility of spine formation/elimination within the time scale of minutes. 86 Post hoc analysis of dendritic spine and synapse density or shape will thus not allow us to gain insight into how anesthetics modulate these highly dynamic processes. On the other hand, since in vivo tracing of dendritic spine plasticity is only feasible under GA, these experiments would be hindered by the necessity of exposing the animals to anesthetics. To circumvent this issue, we took advantage of organotypic hippocampal slice cultures in which the 3-dimensional organization of neural circuitry is preserved 87 and the temporal dynamics of dendritic spines can be traced using 2-photon confocal microscopy. 88, 89 Using this approach, we have shown that the GA-induced increase in spine density is mediated through an increased rate of protrusion formation, a better stabilization of newly formed spines that, ultimately, led to an increased formation of functional synapses. 84 The fact that both anesthetics that enhance GABA A receptor-mediated inhibition and those blocking N-methyld-aspartate (NMDA) receptor-mediated excitation promoted spine growth and synaptogenesis suggests that GA-induced interference with physiological patterns of E/I balance is a major determinant of this drug-induced synaptic growth process. This possibility is in line with previous observations in which prolonged pharmacological interference with excitatory or inhibitory receptors impaired spine densities and synapse properties. [90] [91] [92] [93] [94] [95] In comparison with these previous reports, our observations demonstrate that spine growth triggered by changes in E/I balance can be extremely fast, and is achieved by blockade of both AMPA and NMDA receptors, indicating that it is very sensitive to NMDA-dependent mechanisms. 84 The functional relevance of this anesthesia-triggered, E/I balance-mediated massive reorganization of synaptic circuitry during the brain growth spurt remains to be determined. In fact, since enhancing GABA A receptors or blocking NMDA channels on inhibitory neurons would enhance excitation, further electrophysiological studies are needed to characterize how exactly GA impacts on E/I balance at the network level. Whatever the case, it is tempting to speculate that the fast regulation of synapse number could adjust the level of excitatory activity required for ensuring plasticity-mediated mechanisms. This could be particularly important at times when synapse turnover is high and selection of appropriate contacts is a major issue.
Whether anesthetic-induced perturbations of synaptogenesis are translated to behavioral or cognitive alterations is an important issue. In this context, previous experimental work suggests a causal link between early anesthesia exposure and impaired cognitive testing in multiple behavioral paradigms at later periods. 57, 96, 97 How these changes are related to impaired neural circuitry development remains to be explored. A growing body of human pathological evidence indicates that many psychiatric and neurological disorders-ranging from mental retardation and autism to Alzheimer's disease and addiction-are accompanied by alterations in spine morphology and synapse number. 98, 99 It is thus tempting to speculate that the anesthetic-induced alterations in synaptic density and structure might stand as a morphological basis underlying impaired neurocognitive performance associated with early anesthesia exposure in humans.
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GENERAL ANESTHETICS AND SYNAPTOGENESIS IN THE ADULT BRAIN: IMPLICATIONS FOR PLASTICITY
As mentioned earlier, the extent of plasticity is significantly reduced in the adult in comparison with the young. 3 This phenomenon correlates well with the time-course of stabilization in the number of synaptic contacts in the human brain. 12, 14 In line with human data, in vivo imaging of dendritic spines in mice reveals decreased turnover rate of these highly dynamic structures in the adult in comparison with the young and adolescent brains. 86, 103 Nevertheless, synapse turnover is maintained to some extent, and recent observations suggest that sensory or motor experience and learning can boost this kind of synaptic plasticity in the adult brain. 68, 103, 104 Cognitive decline in the aging brain is a major public health issue. 105 This pathology, at least in part, can be explained by structural changes that directly affect mechanisms of plasticity. 106 Indeed, region-specific decline in the number of neurons, dendritic branching, and synapse number might have a major impact on cognitive and executive functions. It is, however, important to note that major interindividual differences in cognitive abilities have been found in a group of elderly people in whom postmortem analysis revealed the presence of pathological hallmarks of dementia. 107 In the past 2 decades since these initial observations, it has become clear that these differences can be attributed to the so-called "cognitive reserve," allowing individuals greater neural efficiency and the ability for compensation via the recruitment of additional brain regions. 108 Greater cognitive reserve and thus increased plasticity in the aging population have been shown to be associated with literacy, occupational attainment, engagement in leisure activities, and the integrity of social networks. 108 These important clinical observations provide promising insights and warrant further research as to the capacity to boost plasticity well after the end of critical periods during early life.
Postoperative cognitive dysfunction is a potential complication of perioperative care, [109] [110] [111] which can last for several months and is associated with significant functional limitations and increased mortality. [112] [113] [114] Because providing anesthesia is always associated with a high number of potential confounding factors, among which surgery might play a preponderant role, it is very difficult to define a role for anesthesia exposure itself in these processes in humans. Animal data suggest that administration of GA can indeed underline these deficits. When evaluating the impact of isoflurane/nitrous oxide anesthesia in the absence of surgery on cognitive tasks, Culley et al. found that retrieval of consolidated memory tasks, learned before anesthesia exposure, was seriously affected in aged rats but improved in young animals. 115 On the other hand, acquisition of new tasks was impaired in both age groups, suggesting thereby differential effects of this anesthesia protocol on memory consolidation and acquisition. 116 More recent observations confirm these data and suggest that underlying causes might involve isoflurane-induced inflammatory cytokine expression and related cell injury. 117, 118 In contrast to isoflurane/ nitrous oxide, exposure of rats to propofol anesthesia did not seem to impair acquisition of spatial memory tasks, indicating that postoperative cognitive function might also depend on the kind of anesthetics used. 119 An exciting series of clinical observations suggest that, at least under some pathological states, GA can be clinically significant modulators of neuronal plasticity. Nearly 30 years ago, rapid psychotherapeutic effects of isoflurane anesthesia in treatment-refractory depressed patients were suggested. 120, 121 Importantly, these results were later confirmed in a double-blind comparison with electroconvulsive treatment. 122 More recently, a randomized, placebo-controlled, double-blind crossover study demonstrated robust and rapid antidepressant effects of a single bolus of ketamine when administered at subanesthetic concentrations. 123 The onset of the effect of this NMDA receptor antagonist occurred within 2 hours after injection and remained significant for 1 week. These observations, supported by several subsequent works, 124 raise powerful new therapeutic options in a pathology that is of major public health concern and when weeks or months are required for standard medications to be effective. New experimental observations have provided cellular and molecular insights into the mechanisms underlying these antidepressant effects of ketamine. 125, 126 In these studies, ketamine rapidly activated the mammalian target of rapamycin (mTOR) pathway, leading to an increased number of dendritic spines and improved behavioral response in a rodent model of depression. Ketamine has also been shown to reduce the phosphorylation of eukaryotic elongation factor 2 (eEF2) and a related desuppression of translation of BDNF, which in turn induces fast-acting behavioral antidepressant-like effects. 127 Altogether, these observations clearly suggest a potential for GA to modulate synaptic plasticity in the adult brain. They could also provide potential therapeutic value of these drugs in other neurpsychiatric disorders with impaired neural plasticity such as schizophrenia. 59 Further investigation of these concepts is clearly of fundamental importance.
RELEVANCE OF ANESTHETIC-INDUCED SYNAPTOGENESIS ON EXPERIMENTAL DESIGNS
The fact that at least during the brain growth spurt, anesthetics rapidly and significantly impair dendritic spine growth and synaptogenesis has major technical implications regarding experimental design in studies in which young animals should undergo GA during the early postnatal period for surgery or, most important, for live imaging of dendritic spine plasticity. For example, studies using in vivo 2-photon confocal imaging have reported important pruning in spine number between the 2nd and 4th weeks of life in mice. 128 This is, however, at variance with in vivo studies based on classical staining methods demonstrating a continuous increase in spine densities during this very same period. 9, 129, 130 One plausible explanation for this apparent discrepancy is that the in vivo imaging studies have been performed in mice that had undergone a long anesthesia for the preparation and image acquisition during the 2-photon imaging approach. This manipulation probably boosted spine density in these young mice, and as shown by our studies, 76, 84, 85 analysis in animals anesthetized at approximately postnatal day 15 then suggest a subsequent pruning of spines over the next 2 weeks, while analysis of mice that did not undergo anesthesia conversely indicate a progressive increase in spine density. This example, among probably many others, underlines the importance of anesthesia as an important source of misinterpretation of experimental data during the early postnatal period.
On the basis of the developmental stage-dependent differential effects of anesthetics on synaptic growth, assessing multiple developmental timepoints in experimental studies is of utmost importance in view of human relevance. Initial seminal works revealing the possibility of anesthesia-related developmental neurotoxicity focused on 7-day-old rodent pups. 57, 131, 132 Although it is very difficult to properly extrapolate developmental stages between species, studies attempting to draw temporal correlation between rodent and human brain development suggest that the developmental stage of the 7-day-old rodent brain corresponds to the maturational state of the human brain at the very beginning of the 3rd trimester of pregnancy. 133, 134 In line with these observations, electron microscope data from the rodent cerebral cortex demonstrate only a small number of synaptic contacts in 7-day-old pups while the most intense phase of synaptogenesis occurs between the 15th and 20th postnatal days. 9 Similar intensity of synaptic growth in the human cerebral cortex takes place during the 1st year of postnatal life. 13 Together, these data suggest that administration of anesthetics to 7-day-old rodent pups might reflect drug exposure of midterm fetuses or very premature human neonates, while experiments conducted in 15-to 20-day-old animals would be more relevant to a period situated somewhere during the first few years on the human scale.
CONCLUSIONS
A substantial amount of experimental and clinical data suggest that GAs, in addition to providing a temporary loss of consciousness to facilitate surgery, can also have significant longer-term impact on the CNS. Initially, emphasis has been placed on the neurotoxic effects of these drugs in the developing brain as well as in the aging brain. Nevertheless, during the past few years, an increasing number of observations suggest that anesthetics may also improve neurocognitive function in some pathological states. Experimental works start to decipher the underlying molecular and cellular mechanisms. These studies indicate that anesthetics are powerful modulators of synaptogenesis and thus of neural plasticity. Accordingly, by expanding upon the view that GAs are potential neurotoxins under some conditions, the fact that they are also context-dependent modulators of neural plasticity adds a new level of understanding about how these drugs affect the CNS. E DISCLOSURES Name: Laszlo Vutskits, MD, PhD.
